Monday, October 1, 2018

New, rare mechanism for ALL to relapse after CAR T cell therapy

A single leukemia cell, unknowingly engineered with the leukemia-targeting chimeric antigen receptor (CAR) lentivirus and infused back into a patient, was able to reproduce and cause a deadly recurrence of B-cell acute lymphoblastic leukemia (ALL).

from Top Health News -- ScienceDaily https://ift.tt/2P40eEy
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Hidden blood molecules show surprising anti-aging power

Scientists have identified new anti-aging compounds produced by a little-studied blood bacterium. These indole metabolites were able to redu...